What is the first thing that comes to your mind when you think about a warehouse? Maybe an image of a truck stacking pallets and boxes in a giant hall? However, the warehouse at Biovian …
What does a project manager do and what is needed to be successful in such a position? The job title has a broad meaning and job descriptions for project managers vary greatly. Even within the …
Biovian Oy announces that its Board of Directors has named Antti Nieminen, as a Chief Executive Officer, effective January 1st, 2022. Nieminen succeeds Co-Founder Dr. Knut Ringbom, who will transition to Senior Advisor of Biovian, …
Biovian’s client satisfaction survey was conducted in November using Net Promoter Score (NPS) survey. The score of 67 puts Biovian into the category “Excellent” based on the creators of NPS, Bain & Co. Flexibility, good …
New Horizons 2021 event took place on December 9th in Stockholm. Dr. Magnus Gustafsson from Biovian gave a talk about “Gene therapy today and tomorrow.” New Horizons is an international educational forum that focuses on …
Biovian received a new automated filling line right before Christmas in 2020 from Optima packaging group. This article describes the project from the planning phase until the assembly of the filling line. The project is …
Biovian and Lokon Pharma are featured in Biopharma Dealmakers September issue. The article “Manufacturing the next generation of cancer immunotherapeutics”, describes the history and currents state of Lokon Pharma’s proprietary LOAd technology. This immunostimulatory gene …
Outsourcing as a business model within the Life Science-industry is growing year by year. Choosing the right contract development and manufacturing organization (CDMO) has become an important factor for the success of drug product development. …
Lokon Pharma AB, a company developing next-generation cancer therapeutics, has selected Biovian Oy as a CDMO partner for GMP manufacturing of LOAd703 for a pivotal randomized study. The uniquely engineered LOAd703 oncolytic virus is currently …
GEN, one of the biggest magazines in the field of genetic engineering and biotechnology, discussed with four experts how the relationship between a CDMO and a technology provider can accelerate the transition from academia to …
